Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK-Guided Docetaxel in Senior Breast Cancer
NCT02502864Phase 4Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Feb 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of docetaxel in breast cancer, sponsored by Moffitt Cancer Center. Primary endpoint: Rate of Achieving Targeted Area Under the Curve (AUC) up to 6 months. Started Feb 2016; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02502864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02502864.